Advertisement
Advertisement
U.S. Markets open in 6 mins
Advertisement
Advertisement
Advertisement
Advertisement

MusclePharm Corporation (MSLP)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.19100.0000 (0.00%)
At close: 03:06PM EDT
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close0.1910
Open0.2050
BidN/A x N/A
AskN/A x N/A
Day's Range0.1910 - 0.1910
52 Week Range0.1200 - 2.1700
Volume75
Avg. Volume39,496
Market Cap6.377M
Beta (5Y Monthly)0.24
PE Ratio (TTM)N/A
EPS (TTM)-0.0990
Earnings DateMar 28, 2022 - Apr 01, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • GlobeNewswire

    MusclePharm Announces Private Placement of $2.5 Million Senior Secured Notes

    LAS VEGAS, June 06, 2022 (GLOBE NEWSWIRE) -- MusclePharm Corporation (“MusclePharm” or the “Company”) (OTCPINK: MSLP), a global provider of leading sports nutrition and lifestyle branded nutritional supplements, today announced that it has entered into a definitive agreement with certain institutional and accredited investors pursuant to which the Company has increased its October 2021 offering to provide for the issuance and sale of an additional Senior Secured Notes and warrants (the “Offering

  • GlobeNewswire

    MusclePharm to Present at the LD Micro Invitational XII Conference

    LAS VEGAS, May 24, 2022 (GLOBE NEWSWIRE) -- MusclePharm Corporation (“MusclePharm” or the “Company”) (OTCMKTS: MSLP), a global provider of leading sports nutrition and lifestyle branded nutritional supplements, today announced that Ryan Drexler, the Company’s Chief Executive Officer, and Sabina Rizvi, the Company’s President and Chief Financial Officer, will be presenting at the LD Micro Invitational XII Conference, to be held June 7-9, 2022 at Four Seasons Westlake Village. The MusclePharm inve

  • GlobeNewswire

    MusclePharm Announces First Quarter 2022 Financial Results

    Company Revenue Increases 31% Sequentially to $13.1 Million in First Quarter of 2022 Second Consecutive Quarter of Margin Improvement Despite Industry-Wide Supply Challenges Company Triples MP Performance Energy Sales in First Quarter of 2022 from Fourth Quarter of 2021 to Over $1.1 Million; Delivers Energy Margins of 35% in First Quarter of 2022 LAS VEGAS, May 16, 2022 (GLOBE NEWSWIRE) -- MusclePharm Corporation (“MusclePharm” or the “Company”) (OTCMKTS: MSLP), a global provider of leading spor

Advertisement
Advertisement